Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2015, Article ID 512618, 12 pages
http://dx.doi.org/10.1155/2015/512618
Review Article

Roles of Pyruvate, NADH, and Mitochondrial Complex I in Redox Balance and Imbalance in β Cell Function and Dysfunction

1Department of Pharmaceutical Sciences, UNT System College of Pharmacy, University of North Texas Health Science Center, 3500 Camp Bowie Boulevard, Fort Worth, TX 76107, USA
2Department of Biochemistry and Molecular Biology, Gannan Medical University, Ganzhou, Jiangxi 341000, China

Received 4 September 2014; Revised 26 November 2014; Accepted 27 November 2014

Academic Editor: Chen Wang

Copyright © 2015 Xiaoting Luo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Andrews, J. Carroll, S. Ding, I. M. Fearnley, and J. E. Walker, “Assembly factors for the membrane arm of human complex I,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 47, pp. 18934–18939, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Hirst, “Mitochondrial complex I,” Annual Review of Biochemistry, vol. 82, pp. 551–575, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. P. A. Antinozzi, H. Ishihara, C. B. Newgard, and C. B. Wollheim, “Mitochondrial metabolism sets the maximal limit of fuel-stimulated insulin secretion in a model pancreatic beta cell: a survey of four fuel secretagogues,” The Journal of Biological Chemistry, vol. 277, no. 14, pp. 11746–11755, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Hirst, J. Carroll, I. M. Fearnley, R. J. Shannon, and J. E. Walker, “The nuclear encoded subunits of complex I from bovine heart mitochondria,” Biochimica et Biophysica Acta—Bioenergetics, vol. 1604, no. 3, pp. 135–150, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Carroll, I. M. Fearnley, J. M. Skehel, R. J. Shannon, J. Hirst, and J. E. Walker, “Bovine complex I is a complex of 45 different subunits,” Journal of Biological Chemistry, vol. 281, no. 43, pp. 32724–32727, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Carroll, S. Ding, I. M. Fearnley, and J. E. Walker, “Post-translational modifications near the quinone binding site of mammalian complex I,” The Journal of Biological Chemistry, vol. 288, no. 34, pp. 24799–24808, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. W. G. Kaelin Jr. and S. L. McKnight, “Influence of metabolism on epigenetics and disease,” Cell, vol. 153, no. 1, pp. 56–69, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Braidy, G. J. Guillemin, H. Mansour, T. Chan-Ling, A. Poljak, and R. Grant, “Age related changes in NAD+ metabolism oxidative stress and Sirt1 activity in wistar rats,” PLoS ONE, vol. 6, no. 4, Article ID e19194, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Dölle, J. G. M. Rack, and M. Ziegler, “NAD and ADP-ribose metabolism in mitochondria,” FEBS Journal, vol. 280, no. 15, pp. 3530–3541, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Ying, “NAD+/NADH and NADP+/NADPH in cellular functions and cell death: regulation and biological consequences,” Antioxidants & Redox Signaling, vol. 10, no. 2, pp. 179–206, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Mouchiroud, R. H. Houtkooper, and J. Auwerx, “NAD+ metabolism: a therapeutic target for age-related metabolic disease,” Critical Reviews in Biochemistry and Molecular Biology, vol. 48, no. 4, pp. 397–408, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. K. R. Vinothkumar, J. Zhu, and J. Hirst, “Architecture of mammalian respiratory complex I,” Nature, vol. 515, pp. 80–84, 2014. View at Publisher · View at Google Scholar
  13. M. P. Murphy, “How mitochondria produce reactive oxygen species,” Biochemical Journal, vol. 417, no. 1, pp. 1–13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Hirst, M. S. King, and K. R. Pryde, “The production of reactive oxygen species by complex I,” Biochemical Society Transactions, vol. 36, no. 5, pp. 976–980, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Groeger, F. Doonan, T. G. Cotter, and M. Donovan, “Reactive oxygen species regulate prosurvival ERK1/2 signaling and bFGF expression in gliosis within the retina,” Investigative Ophthalmology and Visual Science, vol. 53, no. 10, pp. 6645–6654, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. L.-J. Yan, “Positive oxidative stress in aging and aging-related disease tolerance,” Redox Biology, vol. 2, no. 1, pp. 165–169, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Szabadkai and M. R. Duchen, “Mitochondria mediated cell death in diabetes,” Apoptosis, vol. 14, no. 12, pp. 1405–1423, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. A. H. V. Schapira, “Human complex I defects in neurodegenerative diseases,” Biochimica et Biophysica Acta—Bioenergetics, vol. 1364, no. 2, pp. 261–270, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. A. H. Schapira, J. M. Cooper, D. Dexter, J. B. Clark, P. Jenner, and C. D. Marsden, “Mitochondrial complex I deficiency in Parkinson's disease,” Journal of Neurochemistry, vol. 54, no. 3, pp. 823–827, 1990. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Fassone and S. Rahman, “Complex I deficiency: clinical features, biochemistry and molecular genetics,” Journal of Medical Genetics, vol. 49, no. 9, pp. 578–590, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. J. M. Cooper, V. M. Mann, D. Krige, and A. H. Schapira, “Human mitochondrial complex I dysfunction,” Biochimica et Biophysica Acta, vol. 1101, pp. 198–203, 1992. View at Google Scholar
  22. P. Bénit, R. Beugnot, D. Chretien et al., “Mutant NDUFV2 subunit of mitochondrial complex I causes early onset hypertrophic cardiomyopathy and encephalopathy,” Human Mutation, vol. 21, no. 6, pp. 582–586, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Leloup, C. Magnan, A. Benani et al., “Mitochondrial reactive oxygen species are required for hypothalamic glucose sensing,” Diabetes, vol. 55, no. 7, pp. 2084–2090, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. M. D. Rosenthal and R. H. Glew, Medical Biochemistry: Human Metabolism in Health and Disease, John Wiley & Sons, 2009.
  25. C. Bouche, S. Serdy, C. R. Kahn, and A. B. Goldfine, “The cellular fate of glucose and its relevance in type 2 diabetes,” Endocrine Reviews, vol. 25, no. 5, pp. 807–830, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. M. M. C. Wamelink, E. A. Struys, and C. Jakobs, “The biochemistry, metabolism and inherited defects of the pentose phosphate pathway: a review,” Journal of Inherited Metabolic Disease, vol. 31, no. 6, pp. 703–717, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Prentki and C. J. Nolan, “Islet β cell failure in type 2 diabetes,” Journal of Clinical Investigation, vol. 116, no. 7, pp. 1802–1812, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. P. E. MacDonald, J. W. Joseph, and P. Rorsman, “Glucose-sensing mechanisms in pancreatic β-cells,” Philosophical Transactions of the Royal Society B: Biological Sciences, vol. 360, no. 1464, pp. 2211–2225, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Maechler, S. Carobbio, and B. Rubi, “In beta-cells, mitochondria integrate and generate metabolic signals controlling insulin secretion,” International Journal of Biochemistry and Cell Biology, vol. 38, no. 5-6, pp. 696–709, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Prentki, F. M. Matschinsky, and S. R. M. Madiraju, “Metabolic signaling in fuel-induced insulin secretion,” Cell Metabolism, vol. 18, no. 2, pp. 162–185, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Reyes and M. L. Cardenas, “All hexokinase isoenzymes coexist in rat hepatocytes,” Biochemical Journal, vol. 221, no. 2, pp. 303–309, 1984. View at Google Scholar · View at Scopus
  32. S. Efrat, M. Tal, and H. F. Lodish, “The pancreatic β-cell glucose sensor,” Trends in Biochemical Sciences, vol. 19, no. 12, pp. 535–538, 1994. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Malmgreh, D. G. Nicholls, J. Taneera et al., “Tight coupling between glucose and mitochondrial metabolism in clonal β-cells is required for robust insulin secretion,” Journal of Biological Chemistry, vol. 284, no. 47, pp. 32395–32404, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Maechler and C. B. Wollheim, “Role of mitochondria in metabolism-secretion coupling of insulin release in the pancreatic β-cell,” BioFactors, vol. 8, no. 3-4, pp. 255–262, 1998. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Maechler and C. B. Wollheim, “Mitochondrial signals in glucose-stimulated insulin secretion in the beta cell,” The Journal of Physiology, vol. 529, no. 1, pp. 49–56, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. D. M. Muoio and C. B. Newgard, “Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes,” Nature Reviews Molecular Cell Biology, vol. 9, no. 3, pp. 193–205, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Maechler, “Mitochondrial signal transduction in pancreatic β-cells,” Best Practice and Research: Clinical Endocrinology and Metabolism, vol. 26, no. 6, pp. 739–752, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Komatsu, M. Takei, H. Ishii, and Y. Sato, “Glucose-stimulated insulin secretion: a newer perspective,” Journal of Diabetes Investigation, vol. 4, no. 6, pp. 511–516, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. F. M. Matschinsky, “Regulation of pancreatic β-cell glucokinase: From basics to therapeutics,” Diabetes, vol. 51, supplement 3, pp. S394–S404, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. F. Matschinsky, Y. Liang, P. Kesavan et al., “Glucokinase as pancreatic β cell glucose sensor and diabetes gene,” The Journal of Clinical Investigation, vol. 92, no. 5, pp. 2092–2098, 1993. View at Publisher · View at Google Scholar · View at Scopus
  41. G. W. Cline, “Fuel-stimulated insulin secretion depends upon mitochondria activation and the integration of mitochondrial and cytosolic substrate cycles,” Diabetes & Metabolism Journal, vol. 35, no. 5, pp. 458–465, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. S. G. Straub and G. W. G. Sharp, “Glucose-stimulated signaling pathways in biphasic insulin secretion,” Diabetes/Metabolism Research and Reviews, vol. 18, no. 6, pp. 451–463, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Huang and J. W. Joseph, “Assessment of the metabolic pathways associated with glucose-stimulated biphasic insulin secretion,” Endocrinology, vol. 155, no. 5, pp. 1653–1666, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. M. C. Sugden and M. J. Holness, “The pyruvate carboxylase-pyruvate dehydrogenase axis in islet pyruvate metabolism: going round in circles?” Islets, vol. 3, no. 6, pp. 302–319, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. E. Heart, G. W. Cline, L. P. Collis, R. L. Pongratz, J. P. Gray, and P. J. S. Smith, “Role for malic enzyme, pyruvate carboxylation, and mitochondrial malate import in glucose-stimulated insulin secretion,” American Journal of Physiology—Endocrinology and Metabolism, vol. 296, no. 6, pp. E1354–E1362, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Jitrapakdee, A. Vidal-Puig, and J. C. Wallace, “Anaplerotic roles of pyruvate carboxylase in mammalian tissues,” Cellular and Molecular Life Sciences, vol. 63, no. 7-8, pp. 843–854, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. S. M. Ronnebaum, O. Ilkayeva, S. C. Burgess et al., “A pyruvate cycling pathway involving cytosolic NADP-dependent isocitrate dehydrogenase regulates glucose-stimulated insulin secretion,” Journal of Biological Chemistry, vol. 281, no. 41, pp. 30593–30602, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. J. N. Patterson, K. Cousteils, J. W. Lou, J. E. M. Fox, P. E. MacDonald, and J. W. Joseph, “Mitochondrial metabolism of pyruvate is essential for regulating glucose-stimulated insulin secretion,” Journal of Biological Chemistry, vol. 289, no. 19, pp. 13335–13346, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Xu, J. Han, Y. S. Long et al., “Malic enzyme is present in mouse islets and modulates insulin secretion,” Diabetologia, vol. 51, no. 12, pp. 2281–2289, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. M. J. MacDonald, “Influence of glucose on pyruvate carboxylase expression in pancreatic islets,” Archives of Biochemistry and Biophysics, vol. 319, no. 1, pp. 128–132, 1995. View at Publisher · View at Google Scholar · View at Scopus
  51. M. J. MacDonald, D. I. McKenzie, T. M. Walker, and J. H. Kaysen, “Lack of glyconeogenesis in pancreatic islets: expression of gluconeogenic enzyme genes in islets,” Hormone and Metabolic Research, vol. 24, no. 4, pp. 158–160, 1992. View at Publisher · View at Google Scholar · View at Scopus
  52. D. Lu, H. Mulder, P. Zhao et al., “13C NMR isotopomer analysis reveals a connection between pyruvate cycling and glucose-stimulated insulin secretion (GSIS),” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 5, pp. 2708–2713, 2002. View at Publisher · View at Google Scholar · View at Scopus
  53. F. Schuit, A. de Vos, S. Farfari et al., “Metabolic fate of glucose in purified islet cells. Glucose-regulated anaplerosis in β cells,” The Journal of Biological Chemistry, vol. 272, no. 30, pp. 18572–18579, 1997. View at Publisher · View at Google Scholar · View at Scopus
  54. S. Farfari, V. Schulz, B. Corkey, and M. Prentki, “Glucose-regulated anaplerosis and cataplerosis in pancreatic β cells: possible implication of a pyruvate/citrate shuttle in insulin secretion,” Diabetes, vol. 49, no. 5, pp. 718–726, 2000. View at Publisher · View at Google Scholar · View at Scopus
  55. P. Maechler and C. B. Wollheim, “Mitochondrial function in normal and diabetic β-cells,” Nature, vol. 414, no. 6865, pp. 807–812, 2001. View at Publisher · View at Google Scholar · View at Scopus
  56. P. Huypens, R. Pillai, T. Sheinin et al., “The dicarboxylate carrier plays a role in mitochondrial malate transport and in the regulation of glucose-stimulated insulin secretion from rat pancreatic beta cells,” Diabetologia, vol. 54, no. 1, pp. 135–145, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. P. R. Huypens, M. Huang, and J. W. Joseph, “Overcoming the spatial barriers of the stimulus secretion cascade in pancreatic β-cells,” Islets, vol. 4, no. 1, pp. 1–116, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. L.-J. Yan, S.-H. Yang, H. Shu, L. Prokai, and M. J. Forster, “Histochemial staining and qualification of dihydrolipoamide dehydrogenase diaphorase activity using blue native PAGE,” Electrophoresis, vol. 28, no. 7, pp. 1036–1045, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. L. J. Yan, “Pathogenesis of chronic hyperglycemia: from reductive stress to oxidative stress,” Journal of Diabetes Research, vol. 2014, Article ID 137919, 11 pages, 2014. View at Publisher · View at Google Scholar
  60. L. D. Dukes, M. S. McIntyre, R. J. Mertz et al., “Dependence on NADH produced during glycolysis for β-cell glucose signaling,” Journal of Biological Chemistry, vol. 269, no. 15, pp. 10979–10982, 1994. View at Google Scholar · View at Scopus
  61. N. Sekine, V. Cirulli, R. Regazzi et al., “Low lactate dehydrogenase and high mitochondrial glycerol phosphate dehydrogenase in pancreatic β-cells: potential role in nutrient sensing,” The Journal of Biological Chemistry, vol. 269, no. 7, pp. 4895–4902, 1994. View at Google Scholar · View at Scopus
  62. M. Casimir, B. Rubi, F. Frigerio, G. Chaffard, and P. Maechler, “Silencing of the mitochondrial NADH shuttle component aspartate-glutamate carrier AGC1/Aralar1 in INS-1E cells and rat islets,” Biochemical Journal, vol. 424, no. 3, pp. 459–466, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. K. Eto, S. Suga, M. Wakui et al., “NADH shuttle system regulates K(ATP) channel-dependent pathway and steps distal to cytosolic Ca2+ concentration elevation in glucose-induced insulin secretion,” The Journal of Biological Chemistry, vol. 274, no. 36, pp. 25386–25392, 1999. View at Publisher · View at Google Scholar · View at Scopus
  64. K. Eto, Y. Tsubamoto, Y. Terauchi et al., “Role of NADH shuttle system in glucose-induced activation of mitochondrial metabolism and insulin secretion,” Science, vol. 283, no. 5404, pp. 981–985, 1999. View at Publisher · View at Google Scholar · View at Scopus
  65. K. Bender, P. Maechler, N. H. McClenaghan, P. R. Flatt, and P. Newsholme, “Overexpression of the malate-aspartate NADH shuttle member Aralar1 in the clonal beta-cell line BRIN-BD11 enhances amino-acid-stimulated insulin secretion and cell metabolism,” Clinical Science, vol. 117, no. 9, pp. 321–330, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. Y. Ido, K. Chang, and J. R. Williamson, “NADH augments blood flow in physiologically activated retina and visual cortex,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 2, pp. 653–658, 2004. View at Publisher · View at Google Scholar · View at Scopus
  67. V. Poitout and R. P. Robertson, “Glucolipotoxicity: fuel excess and β-cell dysfunction,” Endocrine Reviews, vol. 29, no. 3, pp. 351–366, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. N. R. Hwang, S.-H. Yim, Y. M. Kim et al., “Oxidative modifications of glyceraldehyde-3-phosphate dehydrogenase play a key role in its multiple cellular functions,” Biochemical Journal, vol. 423, no. 2, pp. 253–264, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. X. Du, T. Matsumura, D. Edelstein et al., “Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells,” The Journal of Clinical Investigation, vol. 112, no. 7, pp. 1049–1057, 2003. View at Publisher · View at Google Scholar · View at Scopus
  70. J. Sakai, J. Li, K. K. Subramanian et al., “Reactive oxygen species-induced actin glutathionylation controls actin dynamics in neutrophilss,” Immunity, vol. 37, no. 6, pp. 1037–1049, 2012. View at Publisher · View at Google Scholar · View at Scopus
  71. A. P. Robertson, “Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes,” The Journal of Biological Chemistry, vol. 279, no. 41, pp. 42351–42354, 2004. View at Publisher · View at Google Scholar · View at Scopus
  72. V. Poitout and R. P. Robertson, “Minireview: secondary β-cell failure in type 2 diabetes—a convergence of glucotoxicity and lipotoxicity,” Endocrinology, vol. 143, no. 2, pp. 339–342, 2002. View at Publisher · View at Google Scholar · View at Scopus
  73. M. Brownlee, “The pathobiology of diabetic complications: a unifying mechanism,” Diabetes, vol. 54, no. 6, pp. 1615–1625, 2005. View at Publisher · View at Google Scholar · View at Scopus
  74. F. Giacco and M. Brownlee, “Oxidative stress and diabetic complications,” Circulation Research, vol. 107, no. 9, pp. 1058–1070, 2010. View at Publisher · View at Google Scholar · View at Scopus
  75. I. G. Obrosova, “Increased sorbitol pathway activity generates oxidative stress in tissue sites for diabetic complications,” Antioxidants & Redox Signaling, vol. 7, no. 11-12, pp. 1543–1552, 2005. View at Publisher · View at Google Scholar · View at Scopus
  76. J. R. Williamson and Y. Ido, “Linking diabetic complications to sorbitol oxidation, oxidative stress and metabolic suppression,” Journal of Diabetes Metabolism, vol. 3, article 219, Article ID 1000219, 2012. View at Publisher · View at Google Scholar
  77. W. H. Tang, K. A. Martin, and J. Hwa, “Aldose reductase, oxidative stress, and diabetic mellitus,” Frontiers in Pharmacology, vol. 3, article 87, 2012. View at Publisher · View at Google Scholar · View at Scopus
  78. J. R. Williamson, K. Chang, M. Frangos et al., “Hyperglycemic pseudohypoxia and diabetic complications,” Diabetes, vol. 42, no. 6, pp. 801–813, 1993. View at Publisher · View at Google Scholar · View at Scopus
  79. J. S. Teodoro, A. P. Rolo, and C. M. Palmeira, “The NAD ratio redox paradox: Why does too much reductive power cause oxidative stress?” Toxicology Mechanisms and Methods, vol. 23, no. 5, pp. 297–302, 2013. View at Publisher · View at Google Scholar · View at Scopus
  80. I. G. Obrosova, M. J. Stevens, and H.-J. Lang, “Diabetes-induced changes in retinal NAD-redox status: pharmacological modulation and implications for pathogenesis of diabetic retinopathy,” Pharmacology, vol. 62, no. 3, pp. 172–180, 2001. View at Publisher · View at Google Scholar · View at Scopus
  81. C. Yabe-Nishimura, “Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications,” Pharmacological Reviews, vol. 50, no. 1, pp. 21–33, 1998. View at Google Scholar · View at Scopus
  82. C. P. Diggle, M. Shires, D. Leitch et al., “Ketohexokinase: expression and localization of the principal fructose-metabolizing enzyme,” Journal of Histochemistry & Cytochemistry, vol. 57, no. 8, pp. 763–774, 2009. View at Publisher · View at Google Scholar · View at Scopus
  83. R. J. Johnson, B. Rodriguez-Iturbe, C. Roncal-Jimenez et al., “Hyperosmolarity drives hypertension and CKD—water and salt revisited,” Nature Reviews Nephrology, vol. 10, pp. 415–420, 2014. View at Publisher · View at Google Scholar · View at Scopus
  84. Y. Ido, J. R. Nyengaard, K. Chang et al., “Early neural and vascular dysfunctions in diabetic rats are largely sequelae of increased sorbitol oxidation,” Antioxidants & Redox Signaling, vol. 12, no. 1, pp. 39–51, 2010. View at Publisher · View at Google Scholar · View at Scopus
  85. H. Raza, S. K. Prabu, M. A. Robin, and N. G. Avadhani, “Elevated mitochondrial cytochrome P450 2E1 and glutathione S-transferase A4-4 in streptozotocin-induced diabetic rats: tissue-specific variations and roles in oxidative stress,” Diabetes, vol. 53, no. 1, pp. 185–194, 2004. View at Publisher · View at Google Scholar · View at Scopus
  86. H. Raza, S. K. Prabu, A. John, and N. G. Avadhani, “Impaired mitochondrial respiratory functions and oxidative stress in streptozotocin-induced diabetic rats,” International Journal of Molecular Sciences, vol. 12, no. 5, pp. 3133–3147, 2011. View at Publisher · View at Google Scholar · View at Scopus
  87. J. F. Turrens, “Superoxide production by the mitochondrial respiratory chain,” Bioscience Reports, vol. 17, no. 1, pp. 3–8, 1997. View at Publisher · View at Google Scholar · View at Scopus
  88. J. F. Turrens, A. Alexandre, and A. L. Lehninger, “Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria,” Archives of Biochemistry and Biophysics, vol. 237, no. 2, pp. 408–414, 1985. View at Publisher · View at Google Scholar · View at Scopus
  89. K. R. Pryde and J. Hirst, “Superoxide is produced by the reduced flavin in mitochondrial complex I: a single, unified mechanism that applies during both forward and reverse electron transfer,” The Journal of Biological Chemistry, vol. 286, no. 20, pp. 18056–18065, 2011. View at Publisher · View at Google Scholar · View at Scopus
  90. K. Sakai, K. Matsumoto, T. Nishikawa et al., “Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic β-cells,” Biochemical and Biophysical Research Communications, vol. 300, no. 1, pp. 216–222, 2003. View at Publisher · View at Google Scholar · View at Scopus
  91. T. Zhang, Y. Gong, H. Zhou, P. Xie, S. Guan, and W. Yi, “Oxidative stress-the key mechanisms of diabetic peripheral neuropathy,” North American Journal of Medicine and Science, vol. 6, pp. 87–90, 2013. View at Google Scholar
  92. S. Madsen-Bouterse, G. Mohammad, and R. A. Kowluru, “Glyceraldehyde-3-phosphate dehydrogenase in retinal microvasculature: implications for the development and progression of diabetic retinopathy,” Investigative Ophthalmology & Visual Science, vol. 51, no. 3, pp. 1765–1772, 2010. View at Publisher · View at Google Scholar · View at Scopus
  93. I. G. Fantus, “The pathogenesis of the chronic complications of the diabetes mellitus,” Endocrinology Rounds, vol. 2, pp. 1–8, 2002. View at Google Scholar
  94. P. Puthanveetil, D. Zhang, Y. Wang et al., “Diabetes triggers a PARP1 mediated death pathway in the heart through participation of FoxO1,” Journal of Molecular and Cellular Cardiology, vol. 53, no. 5, pp. 677–686, 2012. View at Publisher · View at Google Scholar · View at Scopus
  95. S. D. Funk, A. Yurdagul, and A. W. Orr, “Hyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes,” International Journal of Vascular Medicine, vol. 2012, Article ID 569654, 19 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  96. C. Rask-Madsen and G. L. King, “Vascular complications of diabetes: mechanisms of injury and protective factors,” Cell Metabolism, vol. 17, no. 1, pp. 20–33, 2013. View at Publisher · View at Google Scholar · View at Scopus
  97. R. G. Tilton, “Diabetic vascular dysfunction: links to glucose-induced reductive stress and VEGF,” Microscopy Research and Technique, vol. 57, no. 5, pp. 390–407, 2002. View at Publisher · View at Google Scholar · View at Scopus
  98. L. Tretter and V. Adam-Vizi, “Generation of reactive oxygen species in the reaction catalyzed by α-ketoglutarate dehydrogenase,” The Journal of Neuroscience, vol. 24, no. 36, pp. 7771–7778, 2004. View at Publisher · View at Google Scholar · View at Scopus
  99. A. Hernandez-Mijares, M. Rocha, N. Apostolova et al., “Mitochondrial complex i impairment in leukocytes from type 2 diabetic patients,” Free Radical Biology and Medicine, vol. 50, no. 10, pp. 1215–1221, 2011. View at Publisher · View at Google Scholar · View at Scopus
  100. D. Gupta, C. B. Krueger, and G. Lastra, “Over-nutrition, obesity and insulin resistance in the development of β-cell dysfunction,” Current Diabetes Reviews, vol. 8, no. 2, pp. 76–83, 2012. View at Publisher · View at Google Scholar · View at Scopus
  101. M. Bensellam, D. R. Laybutt, and J.-C. Jonas, “The molecular mechanisms of pancreatic β-cell glucotoxicity: recent findings and future research directions,” Molecular and Cellular Endocrinology, vol. 364, no. 1-2, pp. 1–27, 2012. View at Publisher · View at Google Scholar · View at Scopus
  102. S. Cernea and M. Dobreanu, “Diabetes and beta cell function: from mechanisms to evaluation and clinical implications,” Biochemia Medica, vol. 23, no. 3, pp. 266–280, 2013. View at Publisher · View at Google Scholar · View at Scopus
  103. M. Dunlop, “Aldose reductase and the role of the polyol pathway in diabetic nephropathy,” Kidney International, vol. 58, no. 77, pp. S3–S12, 2000. View at Publisher · View at Google Scholar · View at Scopus
  104. C. Escande, V. Nin, N. L. Price et al., “Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome,” Diabetes, vol. 62, pp. 1084–1093, 2013. View at Publisher · View at Google Scholar
  105. S.-I. Oka, C.-P. Hsu, and J. Sadoshima, “Regulation of cell survival and death by pyridine nucleotides,” Circulation Research, vol. 111, no. 5, pp. 611–627, 2012. View at Publisher · View at Google Scholar · View at Scopus
  106. W. Ying, G. Wei, D. Wang et al., “Intranasal administration with NAD+ profoundly decreases brain injury in a rat model of transient focal ischemia,” Frontiers in Bioscience, vol. 12, no. 7, pp. 2728–2734, 2007. View at Publisher · View at Google Scholar · View at Scopus
  107. L. Virág and C. Szabó, “The therapeutic potential of poly(ADP-ribose) polymerase inhibitors,” Pharmacological Reviews, vol. 54, no. 3, pp. 375–429, 2002. View at Publisher · View at Google Scholar · View at Scopus
  108. E. Pankotai, Z. Lacza, M. Murányi, and C. Szabó, “Intra-mitochondrial poly(ADP-ribosyl)ation: potential role for alpha-ketoglutarate dehydrogenase,” Mitochondrion, vol. 9, no. 2, pp. 159–164, 2009. View at Publisher · View at Google Scholar · View at Scopus
  109. K. Parveen, M. R. Khan, M. Mujeeb, and W. A. Siddiqui, “Protective effects of Pycnogenol on hyperglycemia-induced oxidative damage in the liver of type 2 diabetic rats,” Chemico-Biological Interactions, vol. 186, no. 2, pp. 219–227, 2010. View at Publisher · View at Google Scholar · View at Scopus
  110. A. Maritim, B. A. Dene, R. A. Sanders, and J. B. Watkins III, “Effects of pycnogenol treatment on oxidative stress in streptozotocin-induced diabetic rats,” Journal of Biochemical and Molecular Toxicology, vol. 17, no. 3, pp. 193–199, 2003. View at Publisher · View at Google Scholar · View at Scopus
  111. V. Y. Waisundara, A. Hsu, B. K.-H. Tan, and D. Huang, “Baicalin reduces mitochondrial damage in streptozotocin-induced diabetic Wistar rats,” Diabetes/Metabolism Research and Reviews, vol. 25, no. 7, pp. 671–677, 2009. View at Publisher · View at Google Scholar · View at Scopus
  112. V. Y. Waisundara, A. Hsu, B. K.-H. Tan, and D. Huang, “Baicalin improves antioxidant status of streptozotocin-induced diabetic wistar rats,” Journal of Agricultural and Food Chemistry, vol. 57, no. 10, pp. 4096–4102, 2009. View at Publisher · View at Google Scholar · View at Scopus
  113. S. A. El-Awdan, G. A. Abdel Jaleel, and A. O. Saleh, “Grape seed extract attenuates hyperglycemia-induced in rats by streptozotocin,” Bulletin of Faculty of Pharmacy, Cairo University, vol. 51, pp. 203–209, 2013. View at Google Scholar
  114. R. Gupta, A. K. Sharma, M. C. Sharma, and R. S. Gupta, “Antioxidant activity and protection of pancreatic β-cells by embelin in streptozotocin-induced diabetes,” Journal of Diabetes, vol. 4, no. 3, pp. 248–256, 2012. View at Publisher · View at Google Scholar · View at Scopus
  115. I. C. Chis, M. I. Ungureanu, A. Marton et al., “Antioxidant effects of a grape seed extract in a rat model of diabetes mellitus,” Diabetes and Vascular Disease Research, vol. 6, no. 3, pp. 200–204, 2009. View at Publisher · View at Google Scholar · View at Scopus
  116. K. Prasad, S. V. Mantha, A. D. Muir, and N. D. Westcott, “Protective effect of secoisolariciresinol diglucoside against streptozotocin-induced diabetes and its mechanism,” Molecular and Cellular Biochemistry, vol. 206, no. 1-2, pp. 141–150, 2000. View at Publisher · View at Google Scholar · View at Scopus
  117. D. Gomathi, G. Ravikumar, M. Kalaiselvi, K. Devaki, and C. Uma, “Efficacy of Evolvulus alsinoides (L.) L. on insulin and antioxidants activity in pancreas of streptozotocin induced diabetic rats,” Journal of Diabetes and Metabolic Disorders, vol. 12, no. 1, article 39, 2013. View at Publisher · View at Google Scholar · View at Scopus
  118. O. O. Erejuwa, S. A. Sulaiman, M. S. Wahab, K. N. S. Sirajudeen, M. S. M. D. Salleh, and S. Gurtu, “Antioxidant protection of Malaysian tualang honey in pancreas of normal and streptozotocin-induced diabetic rats,” Annales d'Endocrinologie, vol. 71, no. 4, pp. 291–296, 2010. View at Publisher · View at Google Scholar · View at Scopus
  119. Y. Fujita, M. Hosokawa, S. Fujimoto et al., “Metformin suppresses hepatic gluconeogenesis and lowers fasting blood glucose levels through reactive nitrogen species in mice,” Diabetologia, vol. 53, no. 7, pp. 1472–1481, 2010. View at Publisher · View at Google Scholar · View at Scopus
  120. B. Viollet, B. Guigas, N. Sanz Garcia, J. Leclerc, M. Foretz, and F. Andreelli, “Cellular and molecular mechanisms of metformin: an overview,” Clinical Science, vol. 122, no. 6, pp. 253–270, 2012. View at Publisher · View at Google Scholar · View at Scopus
  121. I. Pernicova and M. Korbonits, “Metformin-mode of action and clinical implications for diabetes and cancer,” Nature Reviews Endocrinology, vol. 10, pp. 143–156, 2014. View at Publisher · View at Google Scholar · View at Scopus
  122. M. Xu, Y. Xiao, J. Yin et al., “Berberine promotes glucose consumption independently of AMP-activated protein kinase activation,” PLoS One, vol. 9, Article ID e103702, 2014. View at Google Scholar
  123. N. Turner, J.-Y. Li, A. Gosby et al., “Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action,” Diabetes, vol. 57, no. 5, pp. 1414–1418, 2008. View at Publisher · View at Google Scholar · View at Scopus
  124. M. Masini, M. Anello, M. Bugliani et al., “Prevention by metformin of alterations induced by chronic exposure to high glucose in human islet beta cells is associated with preserved ATP/ADP ratio,” Diabetes Research and Clinical Practice, vol. 104, no. 1, pp. 163–170, 2014. View at Publisher · View at Google Scholar · View at Scopus
  125. E. Fontaine, “Metformin and respiratory chain complex I: the last piece of the puzzle?” Biochemical Journal, vol. 463, pp. e3–e5, 2014. View at Google Scholar
  126. P. Maechler, “Mitochondrial function and insulin secretion,” Molecular and Cellular Endocrinology, vol. 379, no. 1-2, pp. 12–18, 2013. View at Publisher · View at Google Scholar · View at Scopus
  127. A. Sarre, J. Gabrielli, G. Vial, X. M. Leverve, and F. Assimacopoulos-Jeannet, “Reactive oxygen species are produced at low glucose and contribute to the activation of AMPK in insulin-secreting cells,” Free Radical Biology & Medicine, vol. 52, no. 1, pp. 142–150, 2012. View at Publisher · View at Google Scholar · View at Scopus
  128. C. Tang, P. Han, A. I. Oprescu et al., “Evidence for a role of superoxide generation in glucose-induced β-cell dysfunction in vivo,” Diabetes, vol. 56, no. 11, pp. 2722–2731, 2007. View at Publisher · View at Google Scholar · View at Scopus
  129. S. Lenzen, “Oxidative stress: the vulnerable β-cell,” Biochemical Society Transactions, vol. 36, no. 3, pp. 343–347, 2008. View at Publisher · View at Google Scholar · View at Scopus
  130. C. Tang, K. Koulajian, I. Schuiki et al., “Glucose-induced beta cell dysfunction in vivo in rats: link between oxidative stress and endoplasmic reticulum stress,” Diabetologia, vol. 55, no. 5, pp. 1366–1379, 2012. View at Publisher · View at Google Scholar · View at Scopus
  131. S. Supale, N. Li, T. Brun, and P. Maechler, “Mitochondrial dysfunction in pancreatic β cells,” Trends in Endocrinology & Metabolism, vol. 23, no. 9, pp. 477–487, 2012. View at Publisher · View at Google Scholar · View at Scopus
  132. J. R. Treberg, C. L. Quinlan, and M. D. Brand, “Evidence for two sites of superoxide production by mitochondrial NADH-ubiquinone oxidoreductase (complex I),” The Journal of Biological Chemistry, vol. 286, no. 31, pp. 27103–27110, 2011. View at Publisher · View at Google Scholar · View at Scopus